The UPMC Liver Transplant Program’s expertise and innovation includes transplant oncology — a treatment option in which doctors remove a patient’s cancerous liver and replace it with part of a living donor’s healthy liver.
The donated liver portion regrows to its original size, usually a few months after transplant. The donor’s liver regrows too.
Living-donor liver transplant can be an earlier and faster treatment for patients with advanced cancers.
UPMC offers living-donor liver transplantation as a treatment option for patients with these cancer diagnoses:
- Hepatocellular carcinoma (HCC).
- Hilar cholangiocarcinoma.
- Intrahepatic cholangiocarcinoma or mixed cholangio/hepatocellular carcinoma.
- Unresectable metastatic colorectal cancer.
- Unresectable neuroendocrine tumor.